Friday 30 September 2016

Global Surgery Tourniquets 2016 Market Report; Launched via MarketResearchReports.com

Global Surgery Tourniquets Market Research Report 2016

2016 Global Surgery Tourniquets Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Surgery Tourniquets industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Surgery Tourniquets basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Surgery Tourniquets industry; 3.) the North American Surgery Tourniquets industry; 4.) the European Surgery Tourniquets industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Spanning over 153 pages Global Surgery Tourniquets Market Research Report 2016” report covers Surgery Tourniquets Industry Overview, Asia Surgery Tourniquets Industry, North American Surgery Tourniquets Industry, Europe Surgery Tourniquets Industry Analysis, Surgery Tourniquets Marketing Channels and Investment Feasibility, Global Surgery Tourniquets Industry Conclusions.

For more information Visit at: http://mrr.cm/3Ga

Related Reports:

Global Biological Indicator Incubator Market Research Report 2016 - Visit at - http://mrr.cm/3GR

Global Perineal Care Market Research Report 2016 - Visit at - http://mrr.cm/3GD

Global Cold Therapy Market Research Report 2016 - Visit at - http://mrr.cm/3Gz

Global Medical Autoclaves Market Research Report 2016 - Visit at - http://mrr.cm/3GK

Global Refurbished Medical Devices Market to grow at a CAGR of 7.39% during the period 2016 - 2020; Finds New Report

Global Refurbished Medical Devices Market 2016 - 2020

Report forecast the global refurbished medical devices market to grow at a CAGR of 7.39% during the period 2016-2020.

Refurbishment involves restoring equipment to its original condition without altering any of the product's specifications. The process ensures maintenance of the safety and efficacy of the medical equipment without altering its performance. Therefore, refurbishment varies from the replacement of worn parts to cosmetic changes to complete the end-to-end manufacturing process. Usually, the replacement cycle depends on the agreement between vendor and end-user. For most refurbished medical devices, the replacement is done after 3-5 years and depends on the working condition of the device.

The report covers the present scenario and the growth prospects of the global refurbished medical devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of global refurbished medical devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, one of the key drivers for market growth will be rise in privatization in healthcare sector. Privatization is usually profit driven, and the management has autonomous control over the quality and pricing of the procedures performed. Along with privatization, the demand for high standards of treatment has increased leading to the procurement of advanced devices for patient treatment was observed. Many healthcare institutions like hospitals and diagnostic centers have purchased high-cost equipment at a relatively lower price in the form of refurbished devices. Most of them included diagnostic equipment, few to quote such as X-ray, CT, and MRI machines. The refurbished devices enabled these healthcare institutions to equip fully with various costly devices. The equipping of devices by those institutions move ahead of their competitors by providing a wide range of services to patients at low cost.

Further, the report states that availability of remanufactured devices will be a challenge for the market. A refurbished product requires only the replacement of worn-out parts and cleaning of the medical devices. The remanufacturing of medical devices is an expensive procedure, but it is more precise and works toward achieving a higher standard compared to refurbishing of medical devices. Though the installation costs for remanufactured medical equipment increases the capital investment, it also enhances the affordability of the latest technology. The demand from hospitals and ASCs for remanufactured devices has created opportunities for manufacturers in Asia to provide these devices at low cost. Eventually, they will provide a tough competition to refurbished devices.

Global Refurbished Medical Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global refurbished medical devices market: GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems, Agito Medical, Block Imaging International, DRE Medical, Everx, Integrity Medical Systems, Radiology Oncology Systems, Soma Technology, and Stryker.

Market driver
  • Increased sales through online marketing
  • For a full, detailed list, view our report

Market challenge
  • Concerns regarding quality, safety, and efficacy
  • For a full, detailed list, view our report

Market trend
  • OEMs with strategic partnerships to propel refurbished devices market
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Spanning over 65 pages and 46 Exhibit Global Refurbished Medical Devices Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by product, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/3GC

Related Reports;

Global Anesthesia Breathing Circuits Market 2016-2020 - Visit at - http://mrr.cm/3Gy

Global mAb Biosimilars Market 2016-2020 - Visit at - http://mrr.cm/3GF

Global Invisible Orthodontics Market 2016-2020 - Visit at - http://mrr.cm/3Gt

Global Clinical Reference Laboratory Services Market 2016-2020 - http://mrr.cm/3Gv

Global Low Frequency Therapeutic Instrument Industry 2016 Market Report; Launched via MarketResearchReports.com

Global Low Frequency Therapeutic Instrument Industry Market Research 2016

In this report, we analyze the Low Frequency Therapeutic Instrument industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2011 to 2016. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2011 to 2016. We also make a prediction of its production and consumption in coming 2016-2021.

At the same time, we classify different Low Frequency Therapeutic Instrument based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Low Frequency Therapeutic Instrument industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Spanning over 214 pages Global Low Frequency Therapeutic Instrument Industry Market Research 2016” report covers Industry Overview of Low Frequency Therapeutic Instrument, Industry Chain Analysis of Low Frequency Therapeutic Instrument, Manufacturing Technology of Low Frequency Therapeutic Instrument, Major Manufacturers Analysis of Low Frequency Therapeutic Instrument, Global Production, Revenue and Price Analysis of Low Frequency Therapeutic Instrument by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Low Frequency Therapeutic Instrument 2011-2016, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Low Frequency Therapeutic Instrument by Regions, Gross and Gross Margin Analysis of Low Frequency Therapeutic Instrument, Marketing Trader or Distributor Analysis of Low Frequency Therapeutic Instrument, Global and Chinese Economic Impact on Low Frequency Therapeutic Instrument Industry, Development Trend Analysis of Low Frequency Therapeutic Instrument, Contact information of Low Frequency Therapeutic Instrument, New Project Investment Feasibility Analysis of Low Frequency Therapeutic Instrument, Conclusion of the Global Low Frequency Therapeutic Instrument Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/3Gd

Related Reports;

Global Non-invasive Electronical Sphygmomanometer Industry Market Research 2016 - Visit at - http://mrr.cm/3GP

Global Molecular Sieve Industry Market Research 2016 - Visit at - http://mrr.cm/3GW

Global Turbine Dental Drill Industry Market Research 2016 - Visit at - http://mrr.cm/3Gm

Wednesday 28 September 2016

Global Endometriosis - API Manufacturers, Marketed and Phase III Drugs Landscape, 2016; New Report Launched

Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Endometriosis Report is to understand the market and pipeline status of the drugs around the Endometriosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Publisher’s Report provides the historical and forecasted sales of the drugs till 2018.

The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Endometriosis. While the leading brands, companies and chemicals are considered thoroughly, Publisher’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

SCOPE:
  • A snapshot of the global Market and Phase III therapeutics scenario for Endometriosis.
  • A review of the marketed products under prescription for Endometriosis, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Endometriosis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
  • Coverage of API Manufacturers for Endometriosis drugs in the United States, Europe and Asian Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Endometriosis drugs.
  • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Endometriosis drugs.
  • Coverage of Endometriosis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
  • Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
  • Key discontinued Marketed products.
  • Global Sales Figure to 2018. 

Reasons to buy
  • Evaluate the marketing status and exclusivity details of Endometriosis key products to exploit opportunities for generic drug development opportunities.
  • Identify and understand important and diverse types of therapeutics under Phase III development for Endometriosis.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Endometriosis.
  • API intelligence over marketed drugs forEndometriosisand gaining primary intelligence over active ingredients manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline drugs.
  • Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
  • Understanding the scope of the Phase III Drugs with nil regulatory filings.
  • Understanding the chemical route of synthesis of approved drugs for Endometriosis.
  • Uncovering opportunities in the rapidly growing US market.

Spanning over 100 pages Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report covers Indication Overview, Market Drugs Landscape, Global API Manufacturers Assessment, Phase III Drugs Landscape, Drugs Market Data and Forecasted Sales Figure-2018, Marketed Drugs for Endometriosis, Phase III Drugs for Endometriosis, Discontinued Drugs for Endometriosis, Appendix.

For more information Visit at: http://mrr.cm/3ph

Related Reports:

Enterobacteriaceae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3p7

Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - http://mrr.cm/3p8

Essential Thrombocythemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3pX

Ewing Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3pB

Global Blood Glucose Test Strip Industry 2016 Market Report; Launched via MarketResearchReports.com

Global Blood Glucose Test Strip Industry Market Research 2016

In this report, we analyze the Blood Glucose Test Strip industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2011 to 2016. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2011 to 2016. We also make a prediction of its production and consumption in coming 2016-2021.

At the same time, we classify different Blood Glucose Test Strip based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Blood Glucose Test Strip industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Spanning over 216 pages Global Blood Glucose Test Strip Industry Market Research 2016” report covers Industry Overview of Blood Glucose Test Strip, Industry Chain Analysis of Blood Glucose Test Strip, Manufacturing Technology of Blood Glucose Test Strip, Major Manufacturers Analysis of Blood Glucose Test Strip, Global Production, Revenue and Price Analysis of Blood Glucose Test Strip by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Blood Glucose Test Strip 2011-2016, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Blood Glucose Test Strip by Regions, Gross and Gross Margin Analysis of Blood Glucose Test Strip, Marketing Trader or Distributor Analysis of Blood Glucose Test Strip, Global and Chinese Economic Impact on Blood Glucose Test Strip Industry, Development Trend Analysis of Blood Glucose Test Strip, Contact information of Blood Glucose Test Strip, New Project Investment Feasibility Analysis of Blood Glucose Test Strip, Conclusion of the Global Blood Glucose Test Strip Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/3pT

Related Reports;

Global Naproxen Sodium Injection Industry Market Research 2016 - Visit at - http://mrr.cm/3pq

Global Blood Glucose Monitoring System Industry Market Research 2016 - Visit at - http://mrr.cm/3pc

Global Radiotherapy Simulator Industry Market Research 2016 - Visit at - http://mrr.cm/3pp

Global Skin Thermometer Industry Market Research 2016 - Visit at - http://mrr.cm/3pG

Global Cardiomyopathy - API Manufacturers, Marketed and Phase III Drugs Landscape, 2016; New Report Launched

Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Cardiomyopathy Report is to understand the market and pipeline status of the drugs around the Cardiomyopathy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Publisher’s Report provides the historical and forecasted sales of the drugs till 2018.

The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Cardiomyopathy. While the leading brands, companies and chemicals are considered thoroughly, Publisher’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
  • A snapshot of the global Market and Phase III therapeutics scenario for Cardiomyopathy.
  • A review of the marketed products under prescription for Cardiomyopathy, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Cardiomyopathy with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
  • Coverage of API Manufacturers for Cardiomyopathy drugs in the United States, Europe and Asian Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Cardiomyopathy drugs.
  • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Cardiomyopathy drugs.
  • Coverage of Cardiomyopathy Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
  • Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
  • Key discontinued Marketed products.
  • Global Sales Figure to 2018.

Reasons to buy
  • Evaluate the marketing status and exclusivity details of Cardiomyopathy key products to exploit opportunities for generic drug development opportunities.
  • Identify and understand important and diverse types of therapeutics under Phase III development for Cardiomyopathy.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Cardiomyopathy.
  • API intelligence over marketed drugs forCardiomyopathyand gaining primary intelligence over active ingredients manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline drugs.
  • Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
  • Understanding the scope of the Phase III Drugs with nil regulatory filings.
  • Understanding the chemical route of synthesis of approved drugs for Cardiomyopathy.
  • Uncovering opportunities in the rapidly growing US market.

Spanning over 100 pages Cardiomyopathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report covers Indication Overview, Market Drugs Landscape, Global API Manufacturers Assessment, Phase III Drugs Landscape, Drugs Market Data and Forecasted Sales Figure-2018, Marketed Drugs for Cardiomyopathy, Phase III Drugs for Cardiomyopathy, Discontinued Drugs for Cardiomyopathy, Appendix.

For more information Visit at: http://mrr.cm/3pW

Related Reports:

Cerebral Palsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3pm

Cervical Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3ps

Chicken Pox-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3pe

Cholera-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 - Visit at - http://mrr.cm/3pn

Friday 23 September 2016

The Top 100 Distributors of IVD Reagents, Instruments & Accessories Worldwide; New Report Launched

The Top 100 Distributors of IVD Reagents, Instruments & Accessories Worldwide

Did you know?
  • Abacus ALS is the largest privately owned supplier of in-vitro diagnostics products in Australia & New Zealand.
  • Cruinn Diagnostics, one of Ireland's foremost distributors of in-vitro diagnostics has a broad product portfolio that includes clinical chemistry, immunoassay, haematology, microbiology, autoimmune serology and molecular diagnostics.
  • Diachel SA is the leading independent in-vitro diagnostics distributor in Greece, offering complete laboratory solutions, from sales to after-sales support and service.
  • Pera Medikal, one of Turkey’s leading importers of medical diagnostic products, represents over thirty international manufacturers.
  • For 30 years, Laboratorios LICON has specialised in providing reagents and clinical diagnostic systems to both public and private hospitals and laboratories across Mexico.
  • ILEX South Africa is one of the major suppliers of in-vitro diagnostics products in South Africa with a portfolio that includes molecular diagnostics, critical care and immunology products.
  • Biomedica is a prominent distributor of in-vitro diagnostics in Albania, Austria, Bosnia & Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Kosovo, Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia and Switzerland.

This unique and comprehensive report profiles the top 100 distributors of IVD reagents, instruments, and accessories worldwide. These companies partner with leading manufacturers and sell their products to hospitals and laboratories in Africa, Asia/Pacific, the Americas, Europe, the Middle East and the United States.

Profile information for each company in ‘The Top 100 Distributors of IVD Reagents, Instruments & Accessories in Worldwide' typically includes:

Company Contact Information Address, Telephone and Fax Numbers, Email and Website Addresses
Key Company Decision Makers From CEO and Main Board, to Key Senior Managers
Specialised fields such as Company Description, Ownership, Manufacturers Represented, Countries Served, Year Established and Number of Employees.

Report Target Market:

1) Manufacturers

This report is perfect for manufacturers of IVD products who wish to identify all the leading distributors for their products worldwide.

2) Distributors

Usage: competitive analysis and strategic partner/alliance identification.

3) IVD Associations

‘The Top 100 Distributors of IVD Reagents, Instruments & Accessories Worldwide' is ideal for IVD associations to identify new member companies.

Report data field structure is as follows:
  • Company Name
  • Address
  • Telephone
  • Fax
  • Email
  • Website
  • Parent Company
  • Year Established
  • Number of Employees
  • Key Executives
  • Company Description
  • Manufacturers Represented
  • Countries Served
  • Location Status
  • Ownership

The world’s leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It’s customers include most of the world’s major companies in these sectors e.g. Abbott Laboratories, Alcon, Allergan, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomet, Boehringer Ingelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Zentiva etc.. Publisher also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.

Publisher currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

This reports help you make informed decisions about the markets and organisations that affect your business.
  • Learn more about your target markets and target companies
  • Top level research on all the major players in a market
  • See which organisations dominate your major markets
  • Get detailed information on particular organisations

For more information Visit at: http://mrr.cm/3qY

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

The Top 200 Point-Of-Care Diagnostics Companies Worldwide; New Report Launched

The Top 200 Point-Of-Care Diagnostics Companies Worldwide

Did you know?
  • EKF Diagnostics Holdings plc sold over 18,000 point-of-care analysers in 2014.
  • Marcel van Kasteel is Vice President & General Manager at Philips Handheld Diagnostics.
  • Trinity Biotech plc’s point-of-care revenues increased from $19.8m in 2013 to $20.0m in 2014, which represents an increase of 1.4%.
  • Micronics, Inc., a leading developer of near-patient point-of-care in vitro diagnostic products, is a wholly owned subsidiary of Sony Corporation of America.
  • Una Health Ltd., the fastest growing diagnostic distributor in the United Kingdom, specialises in bringing innovative point-of-care devices to the market.
  • BHR Diagnostics Pvt. Ltd. works with leading global manufacturers to bring point-of-care medical diagnostics in six major fields; allergy, cardiovascular, diabetes, female health, gastrointestinal and haematology to the Indian market.
  • Beam International Inc. supplies over 80% of Taiwan’s hospitals and medical centres with point-of-care testing products from leading international manufactures.

These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 200 Point-Of-Care Diagnostics Companies Worldwide’.

There are many in vitro diagnosticscompanies. This report profiles those with a focus on point-of-care.

The companies profiled in this report are located across the globe from North and South America to EMEA, Asia and Oceania. They are the ones with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that compete effectively in global markets.

Report Target Market:

1) Point-Of-Care Diagnostics Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Suppliers

‘The Top 200 Point-Of-Care Diagnostics Companies Worldwide’ is perfect for suppliers of raw materials, technology and services to identify top potential customers.

3) IVD Industry Associations:

This report is ideal for IVD industry associations to identify new member companies.

Profile information for each company in ‘The Top 200 Point-Of-Care Diagnostics Companies Worldwide’ typically includes:
  • Company Name
  • Address
  • Telephone
  • Fax
  • Email
  • Website
  • Year Established
  • Number of Employees
  • Key Executives
  • Company Description
  • POC Focus
  • Companies Represented (POC Distribution Companies only)
  • Countries Served (POC Distribution Companies only)
  • Revenue ($U.S. million) 
  • Ownership
  • Ticker Symbol
  • Parent Company Name

The world’s leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It’s customers include most of the world’s major companies in these sectors e.g. Abbott Laboratories, Alcon, Allergan, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomet, BoehringerIngelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Zentiva etc.. Publisher also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.

Publisher currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

This reports help you make informed decisions about the markets and organisations that affect your business.
  • Learn more about your target markets and target companies
  • Top level research on all the major players in a market
  • See which organisations dominate your major markets
  • Get detailed information on particular organisations

For more information Visit at: http://mrr.cm/3qg

Find all Medical Devices Reports at: http://www.marketresearchreports.com/healthcare

Global RFID Blood Monitoring Systems Market to grow at a CAGR of 22.96% during the period 2016-2020; Finds New Report

Global RFID Blood Monitoring Systems Market 2016 - 2020

Report forecast the global RFID blood monitoring systems market to grow at a CAGR of 22.96% during the period 2016-2020.

RFID is a technology that works on the basis of an electronic circuit or tag. These are either self-powered (using a battery) or powered intermittently through radiation from a distance. These devices can send information to a reader placed at a distance. The tags are plain antennae bonded to a silicon chip placed inside a plastic or glass case. RFID tags contain electronically stored information, which can be used for tracking objects. The healthcare industry is becoming aware of the several uses of RFID, especially to promote efficiency in the tracking and monitoring of products and devices and prevent manual error. RFID blood monitoring systems include blood refrigerators and freezers.

The report covers the present scenario and the growth prospects of the global RFID blood monitoring systems market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of RFID blood monitoring systems to hospitals, blood banks, and research laboratories.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, robust guidelines enabling use of RFID for blood monitoring is a key driver contributing to this market’s growth. The International Society of Blood Transfusion (ISBT) Working Party on Information Technology voted in 2006 to form a task force on RFID to review the state of RFID development and recommend guidelines for the application of RFID in transfusion medicine. The guidelines cover the use of RFID in the blood product supply chain from bag manufacturing to the donor and the individual. ISBT128 provides data structures related to manufacturers of blood bags, namely the container lot number, container manufacturer and catalog number, and the expiry date. Eventually in 2007, the Transfusion Medicine RFID Consortium was formed to research the applicability of RFID methods and devices to identify and track blood products from the point of collection and distribution to final disposition or transfusion. Also, in May 2013, the US FDA approved the use of a RFID device, iTrace, to store and track the manufacturing information of blood products including the collection, processing, and labeling of the component. Such initiatives will support market growth during the forecast period.

Further, the report states that high initial investment and maintenance cost is a major challenge this market is facing. The high initial costs of RFID systems have restricted adoption of these devices. The start-up costs of RFID implementation in an 800-bed hospital will be in the range of $20,000 to $1 million, depending on the requirement. Also, according to the College of American Pathologists, RFID tags were 10-15 times more expensive than barcode systems. A passive tag costs between $0.1 (10 cents) and $0.5 (50 cents), while active tags are priced between 50 cents and $50. This has resulted in the slow adoption of RFID in blood monitoring. Another reason for slow adoption of RFID in hospitals is high maintenance costs. These factors will have a significant impact on the growth of the market.

Global RFID Blood Monitoring Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global RFID blood monitoring systems market: Biolog-Id, Mediware Information Systems, S3Edge, SATO Vicinity, and Terso Solutions.

Other Prominent Vendors in the market are: Honeywell, LogiTag, Mobile Aspects, Nordic ID, Solstice Medical, Stanley Healthcare, TAGSY RFID, WaveMark, and Zebra Technologies.

Market driver
  • Robust guidelines enabling use of RFID for blood monitoring
  • For a full, detailed list, view our report

Market challenge
  • High initial investment and maintenance cost
  • For a full, detailed list, view our report

Market trend
  • Growing adoption of RFID-based solutions for efficient blood monitoring
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Spanning over 65 pages and 37 Exhibit Global RFID Blood Monitoring Systems Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Blood bank funding and financial stability, Harmonization of biobanking/blood banking, Market segmentation by product type, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/3q2

Related Reports;

Global Neurological Biomarkers Market 2016-2020 - Visit at - http://mrr.cm/3q6

Global Intracranial Pressure Monitoring Market 2016-2020 - Visit at - http://mrr.cm/3qu

Global Anterior Cervical Fixation Devices Market 2016-2020 - Visit at - http://mrr.cm/3qL

Global Surgical Power Tools Market 2016-2020 - Visit at - http://mrr.cm/3qb

Thursday 22 September 2016

Global Infection Control Market is expected to reach $22,582 million by 2022; Finds New Report

Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022

Healthcare associated infections which mainly includes hospital or community acquired infections are persisting factor in each and every healthcare system. Increase in occurrence of hospital acquired infections and advancements in sterilization and disinfection technologies are making the infection prevention and control market promising. For reduction of hospital acquired infections, infection prevention control organizations are applying epidemiologic and scientific principles and statistic analysis. Along with this, from the past decade there is a progressive refinement in sterilizing technologies from manually operated equipment to modern microprocessor controlled automatic machines. Plasma sterilization and use of electrostatics for surface disinfection are emerging and promising technologies in sterilizers and disinfectant market. Infection control products are used in a wide variety of applications like in healthcare settings, food and beverage industries, drug discovery, dental clinics and cosmetics. In recent times there is an advancement in sterilizing surgical tools in hospital settings by using robotic surgical tool sterilization process and thus promoting sufficient process of sterilization.

The global infection control market is expected to grow at a single digit high CAGR% to reach $22,582 million by 2022. Infection control market is mainly classified into products and end-users.

The infection control market by products is segmented into disinfection and sterilization. The disinfection market is further sub-segmented into the disinfectors which include washers, flushers and UV rays disinfectors, the endoscope reprocessors, the disinfectants and personal protective equipments (PPE). The disinfectants are divided by product type and EPA classification. Hand, skin, instrument and surface disinfectants are categorized under product type while low-level, intermediate level and high level disinfectants are divided under EPA classification segment. The personal protective equipment includes gloves and foot covers, surgical masks and respirators, surgical drapes and gowns, disinfectant wipes and others (protective eye-wears and sterilization wraps).
The infection control by sterilization is classified by methods and services. The sterilization market by method involves the heat sterilization which further includes wet/moist heat sterilization and dry sterilization, the low temperature sterilization including ethylene oxide sterilization (ETO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, peracetic acid, ozone gas, formaldehyde sterilization and chlorine dioxide, the filtration sterilization and the radiation sterilization contains ionizing and non-ionizing radiation.  However the sterilization market by services is segmented into in-house sterilization services and contract sterilization services. Both the in-house and contract sterilization provides ethylene oxide sterilization, gamma sterilization, e-beam sterilization and other sterilization services.

The end-users of infection control market are pharmaceuticals, biotechnology, hospitals, research laboratories and others. The hospital end-user segment consists of dental clinics, nursing centres and ambulatory services, while the other end-users of this market are cosmetics, food and beverage and veterinary. 

Among the products, disinfection segment holds the largest share and sterilization is the fastest growing segment from 2015 to 2022. By end-users, hospital is the largest segment and is the fastest segment from 2015 to 2022. Geographical wise, North America is the largest market, with a share of 39.5% followed by Europe, Asia and Rest of the World. The Asia region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Infection prevention and control market. Growth in the Asia-Pacific market is attributed to implementation of practical evidence based, low cost and simple preventive strategies, obtaining fund research projects via ICMR, DBT and state agencies and training infection control professionals and nurses.

The Infection Control market is expected to grow at a single digit high CAGR during 2015 to 2022. The factors driving the growth of this market are increase in aging population, rising occurrence of hospital acquired infections, increase in number of surgeries performed, proper maintenance of hygiene among hospital staff and increasing awareness among people. While rise in trend for e-beam radiation sterilization through service sterilization industry and growth of single use technology products in developing countries are some of the opportunities that are propelling the growth of the market.  However stringent regulations and economic downturn and saturation are hampering the growth of the market.

The Infection Control global market is a highly fragmented market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the infection control market are 3M Company (U.S.), Advanced Sterilization Products (U.S.), Ansell Limited (Australia), Belimed (Switzerland), Cantel Medical (U.S.), Getinge Group (Sweden), Halyard Health (U.S.), Hartmann Group (Germany), Sterigenics International, Inc., (U.S.) and Steris Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Spanning over 454 pages Infection Control (Disinfection & Sterilization) Global Market - Forecast to 2022” report covers Executive Summary, Introduction, Market Analysis, Infection Control Global Market, By Products, Infection Control Global Market, By End-Users, Regional Analysis, Competitive Landscape, Major Companies. This report Covered 145 Companies few are - 3m Company, Ansell Limited, Cantel Medical, Getinge Group, Halyard Health Inc., Hartmann Group, Johnson & Johnson, Belimed, Sterigenics International Inc., Steris Corporation, Advanced Sterilization Products, Ahlstrom, Ameriwater.

For more information Visit at: http://mrr.cm/3q5

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Global Human Tetanus Immunoglobulin Industry 2016 Market Report; Launched via MarketResearchReports.com

Global Human Tetanus Immunoglobulin Industry Market Research 2016

In this report, we analyze the Human Tetanus Immunoglobulin industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2011 to 2016. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2011 to 2016. We also make a prediction of its production and consumption in coming 2016-2021.

At the same time, we classify different Human Tetanus Immunoglobulin based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Human Tetanus Immunoglobulin industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Spanning over 215 pages Global Human Tetanus Immunoglobulin Industry Market Research 2016” report covers Industry Overview of Human Tetanus Immunoglobulin, Industry Chain Analysis of Human Tetanus Immunoglobulin, Manufacturing Technology of Human Tetanus Immunoglobulin, Major Manufacturers Analysis of Human Tetanus Immunoglobulin, Global Production, Revenue and Price Analysis of Human Tetanus Immunoglobulin by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Human Tetanus Immunoglobulin 2011-2016, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Human Tetanus Immunoglobulin by Regions, Gross and Gross Margin Analysis of Human Tetanus Immunoglobulin, Marketing Trader or Distributor Analysis of Human Tetanus Immunoglobulin, Global and Chinese Economic Impact on Human Tetanus Immunoglobulin Industry, Development Trend Analysis of Human Tetanus Immunoglobulin, Contact information of Human Tetanus Immunoglobulin, New Project Investment Feasibility Analysis of Human Tetanus Immunoglobulin, Conclusion of the Global Human Tetanus Immunoglobulin Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/3Tz

Related Reports;

Global Human Coagulation Factor Industry Market Research 2016 - Visit at - http://mrr.cm/3TK

Global Heparin Sodium Salt Industry Market Research 2016 - Visit at - http://mrr.cm/3Tr

Global Breast Cancer Monoclonal Antibodies Market is expected to reach 13.7 billion by 2020; Finds New Report

Global Breast Cancer Monoclonal Antibodies Market 2016 - 2020

Report forecast the global breast cancer monoclonal antibodies (mAbs) market to post a revenue of 13.7 billion by 2020.

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells. Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell.

The report covers the present scenario and the growth prospects of the global breast cancer monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of branded mAbs and biosimilars used to treat breast cancer.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, exposure to risk factors will be a key driver for market growth. Exposure to risk factors for breast cancer and the decrease in practices that reduce this risk are expected to increase the incidence of breast cancer. The disease is associated with modifiable risk factors such as physical inactivity, alcohol consumption, obesity, and weight gain. For instance, the use of hormonal therapy after menopause and the use of contraceptives are potential risks for developing breast cancer. Oral contraceptives and postmenopausal estrogen-progestogen hormone replacement therapy increase the risk of the developing the disease because they contain synthetic sex hormones. Overweight postmenopausal women have elevated estrogen levels because they have more estrogen-producing fatty tissue. These levels increase the likelihood of developing the disease. Physical activity helps lower estrogen levels, and thus negates the risk factors. Breastfeeding is also known to protect women against breast cancer.

Further, the report states that the number of patients available for clinical studies is less, making it difficult to generate significant comparative data. This is a major challenge in conducting clinical studies and for the market. The participation of sites across multiple geographies is required, but only very few patients are enrolled at each site. This may lead to delays in the recruitment process, which can add to the cost and uncertainty of the program. Pharmaceutical companies developing mAbs conduct clinical trials on a limited patient population. This requires efforts to mitigate the higher risk of uncertainty associated with the use of these drugs and accelerates approval procedures. The US FDA mandates manufacturers to satisfy Risk Evaluation and Mitigation Strategy (REMS) programs that include elements to ensure safe use before and after approval. The assessment of safety labels during clinical trials becomes difficult because of the limited availability of premarket data for the evaluation of mAbs and the smaller patient population.

Global Breast Cancer Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global breast cancer monoclonal antibodies (mAbs) market: Roche, Amgen, and Mylan.

Other Prominent Vendors in the market are: Actavis, Array BioPharma, AstraZeneca, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Celltrion, Chugai Pharmaceutical, Daiichi Sankyo, DARA Biosciences, Eddingpharm, Eisai, Galena Biopharma, GlaxoSmithKline, Halozyme Therapeutics, Hospira, ImmunoGen, Immunomedics, MacroGenics, Merck, Novartis, Oncothyreon, Pfizer, ProStrakan, Puma Biotechnology, Seattle Genetics, Sun Pharmaceutical Industriesf, Synta Pharmaceuticals, and Teva Pharmaceuticals.

Market driver
  • Reimbursement benefits for breast cancer mAbs
  • For a full, detailed list, view our report

Market challenge
  • Absence of adequate diagnosis and screening procedures for early detection
  • For a full, detailed list, view our report

Market trend
  • Emergence of targeted and combination therapies for breast cancer
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Spanning over 88 pages and 56 Exhibit Global Breast Cancer Monoclonal Antibodies Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Breast cancer: Overview, Pipeline portfolio, Market segmentation by type of mAbs, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/3qJ

Related Reports;

Global Point-of-Care Coagulation Testing Market 2016-2020 - Visit at - http://mrr.cm/3q3

Global Fetal and Neonatal Care Equipment Market 2016-2020 - Visit at - http://mrr.cm/3qU

Global Capnography Market 2016-2020 - Visit at - http://mrr.cm/3qw

Global Vascular Guidewires Market 2016-2020 - Visit at - http://mrr.cm/3qi